Study Highlights Treatment Patterns, Costs for DLBCL Not Treated With Stem Cell Transplant
January 19th 2024Most patients in the cohort received rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for first-line therapy; hospitalization was prevalent; and average medical and pharmacy costs were more than $140,000 per patient per year.
Read More
The new Innovation in Behavioral Health (IBH) Model is designed to test for improving outcomes for adults with mental health and substance use disorder; patients with long COVID show prolonged activation of the immune system’s complement system after an acute infection; scientists now believe our bodies benefit most when our sleep is consistent, not just long.
Read More
Evaluating Hair Camouflage as a Tool for Black Women With Alopecia: A Critical Review
January 18th 2024Black women with alopecia often struggle between concealing their hair loss and protecting their fragile scalps, all while seeking to express their cultural identity and build self-confidence.
Read More
CMS has announced new federal rules that require health insurers to streamline requests to cover treatments; nearly 50,000 veterans used the emergency suicide prevention program launched by the Department of Veteran Affairs in 2023; the FDA recently authorized the first artificial intelligence (AI)-powered medical device to help doctors detect the most common forms of skin cancer.
Read More
New Study Series Addresses Racial Inequities in Pediatric Care, Need for Policy Reform
January 17th 2024The findings demonstrate the critical need for immediate policy reforms to tackle structural racism and promote equitable pediatric care in the US for children regardless of race or ethnicity.
Read More
What We’re Reading: Health Insurance Premiums; Drug Price Hikes; Postpartum Depression Pill Access
January 17th 2024Families with workplace health insurance may have missed out on $125,000 in earnings over the past 3 decades due to rising premiums; so far, there have been about 600 drug price hikes in January; experts worry that minority and low-income people will not have easy access to zuranolone, the first FDA-approved postpartum depression pill.
Read More
Ultrasound Cycloplasty, Endoscopic Cyclophotocoagulation Can Reduce IOP in Secondary Glaucoma
January 17th 2024Endoscopic cyclophotocoagulation had better effect at early stages and ultrasound cycloplasty had higher safety and tolerance when treating intraocular pressure (IOP) in patients with secondary glaucoma.
Read More
Online Workshop Reveals Patient, Future Research Priorities in MDS
January 17th 2024Myelodysplastic syndrome is an extremely heterogeneous disease, and there is no definitive cure, so these investigators wanted a better understanding of patients’ priorities regarding their care, quality of life, and communication with the care team.
Read More
POSSUM, Other Scoring Systems Unable to Estimate Perioperative Complications in CRC
January 16th 2024Mortality and morbidity in patients with colorectal cancer (CRC) cannot be accurately predicted using the Physiological and Operative Severity Score for the enumeration of Mortality and Morbidity (POSSUM) in the present day.
Read More
Real-Time CGM Shows Benefits Over Intermittently Scanned CGM in T1D
January 16th 2024In a systematic review and meta-analysis, real-time continuous glucose monitoring (CGM) demonstrated benefits in terms of time in range, hypoglycemia, and hyperglycemia among patients with type 1 diabetes (T1D).
Read More
Gabapentinoid Use in COPD Associated With Increased Severe Exacerbation Risk, Study Says
January 15th 2024Gabapentinoid use, namely gabapentin and pregabalin, was associated with increased risk for severe chronic obstructive pulmonary disease (COPD) exacerbation in patients with epilepsy, neuropathic pain, and other chronic pain.
Read More